Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Feb 20;110(7):768–776. doi: 10.1093/jnci/djx268

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2018. Published by Oxford University Press.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

Figure 2. — Associations between tumor-infiltrating lymphocytes and clinico-pathological variables. Univariate and multivariable associations between tumor-infiltrating lymphocyte and clinico-pathological variables in all invasive lobular carcinoma (ILC) cases and only the estrogen receptor (ER)–positive/human epidermal growth factor receptor 2 (HER2)–negative from our series (A), as well as from the ER-positive/HER2-negative ILC and invasive ductal carcinoma (B) from the BIG 02-98 study. ER = estrogen receptor; IDC = invasive ductal carcinoma; ILC = invasive lobular carcinoma; TIL = tumor-infiltrating lymphocyte.